Pharming Group N.V. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,060.00
5,767.00
-
11,540.00
21,912.00
37,992
Depreciation, Depletion & Amortization
-
-
-
756.00
3,415.00
3,935
Other Funds
9,792.00
697.00
608.00
5,133.00
-
7,372
Funds from Operations
8,293.00
2,573.00
16,422.00
10,709.00
19,222.00
34,555
Changes in Working Capital
-
-
-
705.00
11,114.00
5,242
Net Operating Cash Flow
8,293.00
2,573.00
16,422.00
10,004.00
30,336.00
29,313
Capital Expenditures
21.00
154.00
898.00
1,514.00
6,045.00
Sale of Fixed Assets & Businesses
262.00
-
-
-
-
Net Investing Cash Flow
241.00
654.00
898.00
57,474.00
6,045.00
Issuance/Reduction of Debt, Net
881.00
682.00
14,487.00
63,635.00
2,211.00
Net Financing Cash Flow
21,089.00
17,996.00
14,362.00
67,327.00
4,622.00
Net Change in Cash
12,838.00
15,233.00
2,542.00
294.00
27,856.00
Free Cash Flow
8,314.00
2,727.00
17,320.00
11,197.00
27,088.00
Net Assets from Acquisitions
-
500.00
-
55,960.00
-
Change in Capital Stock
12,178.00
19,375.00
483.00
8,825.00
6,833.00
Exchange Rate Effect
199.00
464.00
416.00
445.00
1,057.00
About Pharming Group
View Profile
